Subacute group N = 17* | Chronic group N = 34† | Left parietal lobe involved N = 7† | Multiple Sclerosis N = 7 | Parkinson’s disease N = 8 | Total N = 73 | ||
---|---|---|---|---|---|---|---|
ICC KVIQ-G 10 (25)* | vis | 0.86 | 0.82 | 0.62 | 0.51 | 0.69 | 0.77 |
95 % CI | 0.66 – 0.95 | 0.67 – 0.90 | −0.10 – 0.92 | −0.67 – 0.94 | 0.10 – 0.89 | 0.66 – 0.85 | |
ICC KVIQ-G 10 (25)* | kin | 0.79 | 0.80 | 0.88 | 0.92 | 0.84 | 0.85 |
95 % CI | 0.51 – 0.92 | 0.64 – 0.89 | −0.52 – 0.98 | 0.66 – 0.99 | 0.44 – 0.97 | 0.77 – 0.90 | |
ICC KVIQ-G 20 (50)* | vis | 0.83 | 0.84 | 0.77 | 0.43 | 0.68 | 0.77 |
95 % CI | 0.60 – 0.94 | 0.71 – 0.92 | 0.20 – 0.96 | −0.35 – 0.87 | 0.08 – 0.93 | 0.65 – 0.85 | |
ICC KVIQ-G 20 (50)* | kin | 0.80 | 0.75 | 0.91 | 0.95 | 0.82 | 0.83 |
95 % CI | 0.54 – 0.92 | 0.56 – 0.87 | 0.61 – 0.98 | 0.75 – 0.99 | 0.39 – 0.96 | 0.74 – 0.89 | |
ICC KVIQ-G total (100) | vis + kin | 0.85 | 0.87 | 0.84 | 0.79 | 0.86 | 0.87 |
95 % CI | 0.64 – 0.94 | 0.77 – 0.94 | 0.38 – 0.97 | 0.26 – 0.96 | 0.48 – 0.97 | 0.80 – 0.92 | |
ICC Imaprax | vis | 0.84 | 0.34 | 0.77 | 0.37 | 0.74 | 0.51 |
95 % CI | 0.62 – 0.94 | 0.005 – 0.60 | 0.19 – 0.95 | −0.40 – 0.85 | 0.14 – 0.95 | 0.32 – 0.66 |